These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1907432)

  • 41. Use of a transcutaneous PO2 regional perfusion index to quantify tissue perfusion in peripheral vascular disease.
    Hauser CJ; Shoemaker WC
    Ann Surg; 1983 Mar; 197(3):337-43. PubMed ID: 6830339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EDTA chelation therapy for atherosclerotic cardiovascular disease.
    Med Lett Drugs Ther; 1994 May; 36(923):48. PubMed ID: 8177139
    [No Abstract]   [Full Text] [Related]  

  • 43. A feasibility double-blind randomized placebo-controlled trial of extracorporeal shockwave therapy as a novel treatment for intermittent claudication.
    Harwood AE; Green J; Cayton T; Raza A; Wallace T; Carradice D; Chetter IC; Smith GE
    J Vasc Surg; 2018 Feb; 67(2):514-521.e2. PubMed ID: 28943002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. THE EFFECT OF LIPEMIA ON PERIPHERAL BLOOD FLOW.
    ZSOTER T; FAM WM; MCGREGOR M
    Can Med Assoc J; 1964 May; 90(21):1203-5. PubMed ID: 14146862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exercise capacity and Doppler pressure measurements in symptomatic peripheral arterial obstructive disease.
    Leder U; Saul T; Frankenstein L; Krack A; Baer H; Poehlmann G; Figulla HR
    Vasa; 2002 May; 31(2):107-10. PubMed ID: 12099140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Double-blind study of the effect of dipyridamole in patients with intermittent claudication].
    Baumgartner I; Schalch I; Bollinger A
    Vasa; 1992; 21(4):387-91. PubMed ID: 1485474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chelation therapy.
    Schachter MB
    Circulation; 1995 Apr; 91(8):2291-2. PubMed ID: 7697860
    [No Abstract]   [Full Text] [Related]  

  • 48. Pentoxifylline in arterial disease of the legs.
    Verhaeghe R; Verstraete M
    Eur J Clin Pharmacol; 1991; 41(6):507-9. PubMed ID: 1815961
    [No Abstract]   [Full Text] [Related]  

  • 49. Photoplethysmographic documentation of improved microcirculation after pentoxifylline therapy.
    Roeren T; LeVeen RF; Nugent L
    Angiology; 1988 Nov; 39(11):929-33. PubMed ID: 3177959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Edta chelation therapy: an ethical problem.
    Christensen K; Theilade D
    Med Hypotheses; 1999 Jul; 53(1):69-70. PubMed ID: 10499828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progression of asymptomatic peripheral artery disease over 1 year.
    Mohler ER; Bundens W; Denenberg J; Medenilla E; Hiatt WR; Criqui MH
    Vasc Med; 2012 Feb; 17(1):10-6. PubMed ID: 22363014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
    Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460.
    Kurklinsky AK; Levy M
    Vasc Med; 2013 Aug; 18(4):234-6. PubMed ID: 23867841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease.
    Mondillo S; Ballo P; Barbati R; Guerrini F; Ammaturo T; Agricola E; Pastore M; Borrello F; Belcastro M; Picchi A; Nami R
    Am J Med; 2003 Apr; 114(5):359-64. PubMed ID: 12714124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.
    Lederman RJ; Mendelsohn FO; Anderson RD; Saucedo JF; Tenaglia AN; Hermiller JB; Hillegass WB; Rocha-Singh K; Moon TE; Whitehouse MJ; Annex BH;
    Lancet; 2002 Jun; 359(9323):2053-8. PubMed ID: 12086757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Chelates in the treatment of occlusive arteriosclerosis].
    Brücknerová O; Tulácek J
    Vnitr Lek; 1972 Aug; 18(8):729-36. PubMed ID: 4626555
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of enalapril on leg muscle blood flow in patients with claudication.
    Sonecha TN; Nicolaides AN; Kyprianou P; Zukowski A; Papadakis K; Vasdekis S; Salmasi AM
    Int Angiol; 1990; 9(1):22-4. PubMed ID: 2212796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A long-term study of policosanol in the treatment of intermittent claudication.
    Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C
    Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of physical training on peripheral vascular disease: a controlled study.
    Mannarino E; Pasqualini L; Menna M; Maragoni G; Orlandi U
    Angiology; 1989 Jan; 40(1):5-10. PubMed ID: 2642671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Vasodilator drugs and obliterating arterial diseases of the lower extremities].
    Larsen OA; Lassen NA
    Ugeskr Laeger; 1967 Sep; 129(36):1168-71. PubMed ID: 5598859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.